Clinical Trial Update: Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase II trial evaluating rituximab with CHOP chemotherapy for primary gastric diffuse large B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Deltasone (prednisone)
• Oncovin (vincristine)
• Rituxan (rituximab)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Primary Gastric Diffuse-Large B-Cell Lymphoma | Phase 2 | Status: COMPLETED